102 results
Page 3 of 6
8-K
166g7w6qyvzm
13 Jan 20
PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension
4:07pm
S-3
EX-1.2
mrn4 gtgcck94p
27 Dec 19
Shelf registration
5:28pm
S-3
ntmuv0tyidld dhl
27 Dec 19
Shelf registration
5:28pm
S-3
EX-4.2
nnhbi 5sl3lri0
27 Dec 19
Shelf registration
5:28pm
8-K
EX-10.1
ws7 70ewyzvzop
9 Apr 19
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
8:01am
DEF 14A
3xc ky9gv
5 Apr 19
Definitive proxy
4:05pm
10-K
i9i bh5uw
26 Mar 19
Annual report
4:45pm